Adenoidectomy, the surgical removal of the adenoid glands of the tonsils, is a common procedure for pediatric patients. Postoperative analgesia for the procedure includes multimodal protocols but often remains undertreated in the home setting, with significant implications for recovery, function, and patient safety.
The severity and duration of postoperative pain after tonsil surgery are well documented. A prospective cohort study of 299 children aged 4–17 years found that high pain levels, defined as a score of 4 or greater on the Faces Pain Scale-Revised, were reported across all surgical and age groups throughout the recovery period. Children reported a mean of 2.9 to 7.9 days with moderate-to-excruciating pain across different types of tonsil surgery.
Despite these high pain scores, analgesic administration at home was frequently suboptimal: approximately one quarter of children received no analgesics during overnight hours on postoperative days one and two, and adherence to prescribed paracetamol dosing was deficient by a mean of 26–38 percentage points across the first three postoperative days¹.
These real-world adherence failures highlight a critical implementation gap between evidence-based prescribing and actual analgesic delivery. The current evidence strongly supports multimodal analgesia as the foundation of postoperative pain management after adenoidectomy and other tonsil surgery. The PROSPECT Working Group’s systematic review of 226 randomized controlled trials identified paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) as the recommended baseline analgesic regimen, to be initiated preoperatively or intraoperatively and continued postoperatively.
A single intraoperative dose of intravenous dexamethasone is additionally recommended for both its analgesic and antiemetic effects, with a minimum effective dose of 0.15 mg/kg in children and 8 mg or more in adults. Opioids are reserved as rescue analgesics given their risk profile, particularly the potential for respiratory depression in children with obstructive sleep apnea—a population that commonly presents for adenotonsillectomy².
A large systematic review and meta-analysis examining 111 published trials involving 7,566 patients confirmed the analgesic efficacy of both NSAIDs and steroids. In the first 24 postoperative hours, NSAIDs produced a statistically significant reduction in pain compared to placebo or opioid controls (mean difference −0.75; 95% CI: −0.87 to −0.63), and this benefit extended to postoperative days three and seven.
Intravenous dexamethasone similarly demonstrated significant pain reduction across multiple postoperative time points, with no associated increase in primary or secondary bleeding rates. Importantly, neither NSAIDs nor steroids were found to increase postoperative bleeding risk—a concern that has historically limited their use but is not substantiated by current evidence³.
Among local anesthetics, only preoperative peritonsillar injection of levobupivacaine demonstrated consistent, homogeneous analgesic benefit extending up to three days postoperatively, while other local anesthetic agents and delivery methods yielded mixed or heterogeneous results insufficient to support routine recommendation³. The PROSPECT guideline further cautions against peritonsillar infiltration as a routine strategy given documented complications including arrhythmia, upper airway obstruction, and intravascular injection, particularly when a basic analgesic regimen of paracetamol and NSAIDs is already in place².
For patients in whom first-line agents are contraindicated, intraoperative ketamine (in children), dexmedetomidine, or preoperative gabapentinoids may be considered as second-line adjuncts, though each carries risks of sedation that require careful contemplation in the ambulatory context². Discharge instructions must explicitly address the importance of around-the-clock analgesic administration, the appropriate use of rescue medication, and the recognition of undertreated pain—areas where caregiver education has been consistently shown to be inadequate¹.
Optimizing postoperative analgesia for outpatient adenoidectomy ultimately requires a structured, evidence-based approach that begins intraoperatively, extends into the home environment, and is supported by clear, actionable patient and caregiver guidance.
References
- Alm, F., Lundeberg, S. & Ericsson, E. Postoperative pain, pain management, and recovery at home after pediatric tonsil surgery. Eur. Arch. Otorhinolaryngol. 278, 451–461 (2021). https://doi.org/10.1007/s00405-020-06367-z
- Aldamluji, N. et al. PROSPECT guideline for tonsillectomy: systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia 76, 947–961 (2021). https://doi.org/10.1111/anae.15299
- Geißler, K., Scham, D., Meißner, W., Schlattmann, P. & Guntinas-Lichius, O. Systematic review and meta-analysis of pain management after tonsillectomy. Sci. Rep. 15, 1476 (2025). https://doi.org/10.1038/s41598-024-85008-5